Home/Filings/4/0001127602-10-016345
4//SEC Filing

Davies Angela M. 4

Accession 0001127602-10-016345

CIK 0000729922other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:51 PM ET

Size

15.0 KB

Accession

0001127602-10-016345

Insider Transaction Report

Form 4
Period: 2010-06-01
Davies Angela M.
Sr. VP and CMO, Oncology
Transactions
  • Disposition from Tender

    Common Stock

    2010-06-03$57.50/sh445$25,5884,991 total
  • Disposition to Issuer

    Common Stock

    2010-06-03$57.50/sh4,975$286,06316 total
  • Sale

    Common Stock

    2010-06-01$57.44/sh298$17,1175,436 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh2,580$148,3500 total
    Exercise: $33.62Exp: 2015-12-15Common Stock (2,580 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh18,900$1,086,7500 total
    Exercise: $38.13Exp: 2015-03-02Common Stock (18,900 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh9,000$517,5000 total
    Exercise: $35.40Exp: 2019-12-14Common Stock (9,000 underlying)
Footnotes (3)
  • [F1]Represents the number of unvested Restricted Stock Units that were canceled in exchange for a cash payment of $57.50 per unit in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc.
  • [F2]These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option.
  • [F3]Includes 16 shares acquired under the OSI Employee Stock Purchase Plan on June 1, 2010.

Issuer

OSI PHARMACEUTICALS INC

CIK 0000729922

Entity typeother

Related Parties

1
  • filerCIK 0001488772

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:51 PM ET
Size
15.0 KB